Cargando…

Analysis of alternative lengthening of telomere markers in BRCA1 defective cells

Telomeres are specialized structures responsible for the chromosome end protection. Previous studies have revealed that defective BRCA1 may lead to elevated telomere fusions and accelerated telomere shortening. In addition, BRCA1 associates with promyelocytic leukemia (PML) bodies in alternative len...

Descripción completa

Detalles Bibliográficos
Autores principales: Kargaran, Parisa K., Yasaei, Hemad, Anjomani‐Virmouni, Sara, Mangiapane, Giovanna, Slijepcevic, Predrag
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113789/
https://www.ncbi.nlm.nih.gov/pubmed/27295426
http://dx.doi.org/10.1002/gcc.22386
_version_ 1782468245661417472
author Kargaran, Parisa K.
Yasaei, Hemad
Anjomani‐Virmouni, Sara
Mangiapane, Giovanna
Slijepcevic, Predrag
author_facet Kargaran, Parisa K.
Yasaei, Hemad
Anjomani‐Virmouni, Sara
Mangiapane, Giovanna
Slijepcevic, Predrag
author_sort Kargaran, Parisa K.
collection PubMed
description Telomeres are specialized structures responsible for the chromosome end protection. Previous studies have revealed that defective BRCA1 may lead to elevated telomere fusions and accelerated telomere shortening. In addition, BRCA1 associates with promyelocytic leukemia (PML) bodies in alternative lengthening of telomeres (ALTs) positive cells. We report here elevated recombination rates at telomeres in cells from human BRCA1 mutation carriers and in mouse embryonic stem cells lacking both copies of functional Brca1. An increased recombination rate at telomeres is one of the signs of ALT. To investigate this possibility further we employed the C‐circle assay that identifies ALT unequivocally. Our results revealed elevated levels of ALT activity in Brca1 defective mouse cells. Similar results were obtained when the same cells were assayed for the presence of another ALT marker, namely the frequency of PML bodies. These results suggest that BRCA1 may act as a repressor of ALT. © 2016 The Authors Genes, Chromosomes & Cancer Published by Wiley Periodicals, Inc.
format Online
Article
Text
id pubmed-5113789
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-51137892016-12-02 Analysis of alternative lengthening of telomere markers in BRCA1 defective cells Kargaran, Parisa K. Yasaei, Hemad Anjomani‐Virmouni, Sara Mangiapane, Giovanna Slijepcevic, Predrag Genes Chromosomes Cancer Research Articles Telomeres are specialized structures responsible for the chromosome end protection. Previous studies have revealed that defective BRCA1 may lead to elevated telomere fusions and accelerated telomere shortening. In addition, BRCA1 associates with promyelocytic leukemia (PML) bodies in alternative lengthening of telomeres (ALTs) positive cells. We report here elevated recombination rates at telomeres in cells from human BRCA1 mutation carriers and in mouse embryonic stem cells lacking both copies of functional Brca1. An increased recombination rate at telomeres is one of the signs of ALT. To investigate this possibility further we employed the C‐circle assay that identifies ALT unequivocally. Our results revealed elevated levels of ALT activity in Brca1 defective mouse cells. Similar results were obtained when the same cells were assayed for the presence of another ALT marker, namely the frequency of PML bodies. These results suggest that BRCA1 may act as a repressor of ALT. © 2016 The Authors Genes, Chromosomes & Cancer Published by Wiley Periodicals, Inc. John Wiley and Sons Inc. 2016-07-26 2016-11 /pmc/articles/PMC5113789/ /pubmed/27295426 http://dx.doi.org/10.1002/gcc.22386 Text en © 2016 The Authors Genes, Chromosomes & Cancer Published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Kargaran, Parisa K.
Yasaei, Hemad
Anjomani‐Virmouni, Sara
Mangiapane, Giovanna
Slijepcevic, Predrag
Analysis of alternative lengthening of telomere markers in BRCA1 defective cells
title Analysis of alternative lengthening of telomere markers in BRCA1 defective cells
title_full Analysis of alternative lengthening of telomere markers in BRCA1 defective cells
title_fullStr Analysis of alternative lengthening of telomere markers in BRCA1 defective cells
title_full_unstemmed Analysis of alternative lengthening of telomere markers in BRCA1 defective cells
title_short Analysis of alternative lengthening of telomere markers in BRCA1 defective cells
title_sort analysis of alternative lengthening of telomere markers in brca1 defective cells
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113789/
https://www.ncbi.nlm.nih.gov/pubmed/27295426
http://dx.doi.org/10.1002/gcc.22386
work_keys_str_mv AT kargaranparisak analysisofalternativelengtheningoftelomeremarkersinbrca1defectivecells
AT yasaeihemad analysisofalternativelengtheningoftelomeremarkersinbrca1defectivecells
AT anjomanivirmounisara analysisofalternativelengtheningoftelomeremarkersinbrca1defectivecells
AT mangiapanegiovanna analysisofalternativelengtheningoftelomeremarkersinbrca1defectivecells
AT slijepcevicpredrag analysisofalternativelengtheningoftelomeremarkersinbrca1defectivecells